BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21237264)

  • 21. Alterations in food intake by opioid and dopamine signaling pathways between the ventral tegmental area and the shell of the nucleus accumbens.
    MacDonald AF; Billington CJ; Levine AS
    Brain Res; 2004 Aug; 1018(1):78-85. PubMed ID: 15262208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A dopamine mechanism is implied in the acquisition and expression of amphetamine and stress-induced effects observed in the lymphocyte subpopulations.
    Assis MA; Pacchioni AM; Collino C; Paz MC; Sotomayor C; Basso AM; Cancela LM
    Eur J Pharmacol; 2008 Apr; 584(2-3):405-14. PubMed ID: 18339370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine receptor antagonists in the nucleus accumbens attenuate analgesia induced by ventral tegmental area substance P or morphine and by nucleus accumbens amphetamine.
    Altier N; Stewart J
    J Pharmacol Exp Ther; 1998 Apr; 285(1):208-15. PubMed ID: 9536012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amphetamine lowers brain stimulation reward (BSR) threshold in alcohol-preferring (P) and -nonpreferring (NP) rats: regulation by D-sub-1 and D-sub-2 receptors in the nucleus accumbens.
    Eiler WJ; Masters J; McKay PF; Hardy L; Goergen J; Mensah-Zoe B; Seyoum R; Cook J; Johnson N; Neal-Beliveau B; June HL
    Exp Clin Psychopharmacol; 2006 Aug; 14(3):361-76. PubMed ID: 16893279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropeptide Y Y1 receptors mediate morphine-induced reductions of natural killer cell activity.
    Saurer TB; Ijames SG; Lysle DT
    J Neuroimmunol; 2006 Aug; 177(1-2):18-26. PubMed ID: 16766046
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute in vivo amphetamine produces a homologous desensitization of dopamine receptor-coupled adenylate cyclase activities and decreases agonist binding to the D1 site.
    Roseboom PH; Gnegy ME
    Mol Pharmacol; 1989 Jan; 35(1):139-47. PubMed ID: 2563306
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Involvement of dopamine D1 and D2 receptors in the nucleus accumbens core and shell in inhibitory response control.
    Pattij T; Janssen MC; Vanderschuren LJ; Schoffelmeer AN; van Gaalen MM
    Psychopharmacology (Berl); 2007 Apr; 191(3):587-98. PubMed ID: 16972104
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Subchronic continuous phencyclidine administration potentiates amphetamine-induced frontal cortex dopamine release.
    Balla A; Sershen H; Serra M; Koneru R; Javitt DC
    Neuropsychopharmacology; 2003 Jan; 28(1):34-44. PubMed ID: 12496938
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopamine D1/D2 Receptor Activity in the Nucleus Accumbens Core But Not in the Nucleus Accumbens Shell and Orbitofrontal Cortex Modulates Risk-Based Decision Making.
    Mai B; Sommer S; Hauber W
    Int J Neuropsychopharmacol; 2015 Apr; 18(10):pyv043. PubMed ID: 25908669
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of amphetamine-induced rotation in rats with unilateral intrastriatal grafts of embryonic dopaminergic neurons: a pharmacological and biochemical analysis.
    Herman JP; Rouge-Pont F; Le Moal M; Abrous DN
    Neuroscience; 1993 Apr; 53(4):1083-95. PubMed ID: 8099430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation.
    Kleijn J; Wiskerke J; Cremers TI; Schoffelmeer AN; Westerink BH; Pattij T
    Neurochem Int; 2012 Jun; 60(8):791-8. PubMed ID: 22426202
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Age-related changes in behavior, in monoamines and their metabolites content, and in density of D1 and D2 dopamine receptors in the brain structures of WAG/Rij rats with depression-like pathology].
    Sarkisova KY; Kulikov MA; Kudrin VS; Midzyanovskaya IS; Birioukova LM
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2014; 64(6):668-85. PubMed ID: 25975143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The amphetamine-associated context exerts a stronger motivational effect in low-anxiety rats than in high-anxiety rats.
    Lehner M; Gryz M; Wisłowska-Stanek A; Turzyńska D; Sobolewska A; Skórzewska A; Płaźnik A
    Behav Brain Res; 2017 Jul; 330():97-107. PubMed ID: 28479265
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The dopamine D1-D2 receptor heteromer localizes in dynorphin/enkephalin neurons: increased high affinity state following amphetamine and in schizophrenia.
    Perreault ML; Hasbi A; Alijaniaram M; Fan T; Varghese G; Fletcher PJ; Seeman P; O'Dowd BF; George SR
    J Biol Chem; 2010 Nov; 285(47):36625-34. PubMed ID: 20864528
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic and intra-accumbens administration of amphetamine differentially affects cortical acetylcholine release.
    Arnold HM; Nelson CL; Neigh GN; Sarter M; Bruno JP
    Neuroscience; 2000; 96(4):675-85. PubMed ID: 10727786
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effects in rats of lisdexamfetamine in combination with olanzapine on mesocorticolimbic dopamine efflux, striatal dopamine D2 receptor occupancy and stimulus generalization to a D-amphetamine cue.
    Hutson PH; Rowley HL; Gosden J; Kulkarni RS; Slater N; Love PL; Wang Y; Heal D
    Neuropharmacology; 2016 Feb; 101():24-35. PubMed ID: 26384654
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of D1- and D2-like dopaminergic receptors in the nucleus accumbens in modulation of formalin-induced orofacial pain: Involvement of lateral hypothalamus.
    Shafiei I; Vatankhah M; Zarepour L; Ezzatpanah S; Haghparast A
    Physiol Behav; 2018 May; 188():25-31. PubMed ID: 29421337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dopaminergic response to graded dopamine concentration elicited by four amphetamine doses.
    Ren J; Xu H; Choi JK; Jenkins BG; Chen YI
    Synapse; 2009 Sep; 63(9):764-72. PubMed ID: 19484725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modafinil-induced conditioned place preference via dopaminergic system in mice.
    Nguyen TL; Tian YH; You IJ; Lee SY; Jang CG
    Synapse; 2011 Aug; 65(8):733-41. PubMed ID: 21157933
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Involvement of the endogenous opioid system in the beneficial influence of physical exercise on amphetamine-induced addiction parameters.
    Rosa HZ; Segat HJ; Barcelos RCS; Roversi K; Rossato DR; de Brum GF; Burger ME
    Pharmacol Biochem Behav; 2020 Oct; 197():173000. PubMed ID: 32702398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.